[1]朱 彤,张 楚,边欣怡,等.正常大小卵巢癌综合征的临床诊疗分析[J].医学信息,2021,34(08):109-112.[doi:10.3969/j.issn.1006-1959.2021.08.028]
　ZHU Tong,ZHANG Chu,BIAN Xin-yi,et al.Clinical Diagnosis and Treatment Analysis of Normal-sized Ovary Carcinoma Syndrome[J].Medical Information,2021,34(08):109-112.[doi:10.3969/j.issn.1006-1959.2021.08.028]
点击复制

正常大小卵巢癌综合征的临床诊疗分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
34卷
期数:
2021年08期
页码:
109-112
栏目:
临床研究
出版日期:
2021-04-15

文章信息/Info

Title:
Clinical Diagnosis and Treatment Analysis of Normal-sized Ovary Carcinoma Syndrome
文章编号:
1006-1959（2021）08-0109-04
作者:
朱 彤; 张 楚; 边欣怡; 等
（华中科技大学同济医学院附属同济医院妇产科1，中西医结合科2，湖北 武汉 430030）
Author(s):
ZHU Tong; ZHANG Chu; BIAN Xin-yi; et al.
(Department of Obstetrics and Gynecology1,Department of Integrated Traditional Chinese and Western Medicine2, Tongji Hospital,Tongji Medical College of HUST,Wuhan 430030,Hubei,China)
关键词:
卵巢肿瘤; 正常大小卵巢癌综合征; 第二苗勒系统; 转移肿瘤
Keywords:
Ovarian tumor; Normal-sized ovary carcinoma syndrome; Second Mullerian system; Metastatic tumor
分类号:
R737.31
DOI:
10.3969/j.issn.1006-1959.2021.08.028
文献标志码:
A
摘要:
目的 探讨正常大小卵巢癌综合征的临床特点、诊断标准及预后。方法 回顾性分析2016年1月~2019年12月在我院治疗及病理证实的35例正常大小卵巢癌综合征患者临床资料，按照组织学来源是否为第二苗勒系统将其分为苗勒组（n=30）与转移组（n=5），比较两组临床表现及预后差异。结果 苗勒组年龄、绝经人数高于转移组，差异有统计学意义（P＜0.05）；两组孕次、产次比较，差异无统计学意义（P＞0.05）；两组腹痛、阴道流血或流液、体检肿瘤标志物增高、胸闷气促发生率及CA125、CEA比较，差异无统计学意义（P＞0.05），苗勒组腹胀发生率、腹水含量高于转移组，CA199低于转移组，差异有统计学意义（P＜0.05）；苗勒组患者行全子宫切除＋双附件切除＋大网膜切除＋盆腔淋巴结清扫术，转移组患者行全子宫切除＋双附件切除＋大网膜切除＋盆腔淋巴结清扫术；苗勒组主要为卵巢原发肿瘤和卵巢外腹膜浆液性乳头状腺癌，转移组主要为来源于胃、阑尾、直肠、消化道的肿瘤；苗勒组9例误诊，转移组2例误诊；两组存活时间比较，差异无统计学意义（P＞0.05）。结论 对于正常大小卵巢癌综合征患者，必须高度重视鉴别诊断，尽早手术探查，尽量切除癌灶，术后辅以有效化疗或放疗，以期获得最佳生存期和预后。
Abstract:
Objective To explore the clinical features, diagnostic criteria and prognosis of normal-sized ovary carcinoma syndrome.Methods A retrospective analysis of the clinical data of 35 patients with normal-sized ovary carcinoma syndrome who were treated and pathologically confirmed in our hospital from January 2016 to December 2019.According to whether the histological source is the second Mullerian system, they are divided into the Mullerian group (n=30) and the metastasis group (n=5).The differences in clinical manifestations and prognosis between the two groups were compared.Results The number of menopausal women and the age in the Mullerian group were higher than those in the metastasis group,the difference was statistically significant (P＜0.05);There was no statistically significant difference in pregnancy times and parity times between the two groups (P＞0.05);There was no statistically significant difference between the two groups of abdominal pain, vaginal bleeding or fluid, increased tumor markers in physical examination, chest tightness and shortness of breath, CA125 and CEA (P＞0.05).The incidence of abdominal distension and ascites content in the Mullerian group was higher than that in the metastasis group, and CA199 was lower than that in the metastasis group, the difference was statistically significant (P＜0.05);Patients in the Mullerian group underwent total hysterectomy + double attachment resection + omentectomy + pelvic lymph node dissection, and patients in the metastasis group underwent total hysterectomy + double attachment resection + omentectomy + pelvic lymph node dissection;The Mullerian group was mainly ovarian primary tumors and extraovarian peritoneal serous papillary adenocarcinoma, and the metastatic group was mainly tumors from the stomach, appendix, rectum, and digestive tract;Nine cases were misdiagnosed in the Mullerian group and 2 cases were misdiagnosed in the metastasis group. There was no significant difference in survival time between the two groups (P＞0.05).Conclusion For patients with normal-sized ovary carcinoma syndrome, it is necessary to attach great importance to the differential diagnosis, surgical exploration as soon as possible, removal of the cancer as much as possible, and effective chemotherapy or radiotherapy after the operation, in order to obtain the best survival and prognosis.

参考文献/References:

[1]Feuer GA,Shevchuk M,Calanog A.Normal-sized ovary carcinoma syndrome[J].Obstet Gynecol,1989,73(5Pt1):786-792. [2]Win TT,Aye SN,Hamad NSA,et al.Primary retroperitoneal serous adenocarcinoma:A case report of rare malignancy with literature review[J].Indian J Cancer,2020:33402586. [3]Cheng Z,Yang W,Guo J,et al.Genetic landscape of a case of extraovarian peritoneal serous papillary carcinoma[J].Oncology Letters,2016,12(4):2395-2402. [4]Yu N,Li X,Yang B,et al.Clinical characteristics and survival of patients with normal-sized ovarian carcinoma syndrome: Retrospective analysis of a single institution 10-year experiment[J].World J Clin Cases,2020,8(21):5116-5127. [5]Reyners AK,Broekman KE,Glaudemans AW,et al.Molecular imaging in ovarian cancer[J].Ann Oncol,2016,27(1):i23-i29. [6]Yong SL,Dahian S,Ramlan AH,et al.The diagnostic challenge of ovarian carcinoma in normal-sized ovaries:a report of two cases[J].Horm Mol Biol Clin Investig,2018,35(1):/j/hmbci.2018.35.issue-1/hmbci-2018-0043/hmbci-2018-0043.xml. [7]苏庆洋,王忠民.卵巢正常大小的卵巢癌综合征辨治探讨[J].湖南中医药大学学报,2018(8):879-884. [8]侯红梅,李明娟,董敏,等.经阴道超声诊断正常大小卵巢卵巢癌综合征的临床价值[J].中国中西医结合影像学杂志,2017,15(4):478-480. [9]韩宇飞,杨瑶,陈龙.卵巢大小正常卵巢癌综合征误诊为右半结肠癌1例报道[J].中国计划生育和妇产科,2019,11(6):94-96. [10]Levy M,Boublíková L,Büchler T,et al.Treatment of Malignant Peritoneal Mesothelioma[J].Klin Onkol,2019,32(5):333-337. [11]郭爽,刘端阳,李静,等.癌性腹水对卵巢癌细胞增殖及迁移的影响[J].实用肿瘤学杂志,2016(1):36-40. [12]Ferrari F,Ficarelli S,Forte S,et al.Extra-abdominal ovarian cancer presenting with breast metastases at diagnosis:Case report and literature review[J].Eur J Obstet Gynecol Reprod Biol,2020(255):211-221. [13]郭喆,冯惠茹,于杨洁,等.18F-FDG PET-CT在卵巢正常大小癌综合征诊断中的应用[J].中国肿瘤临床,2012,39(1):45-47. [14]Thanh Huong P,Gurshaney S,Thanh Binh N,et al.Emerging Role of Circulating Tumor Cells in Gastric Cancer[J].Cancers(Basel),2020,12(3):695. [15]Jiang X,Hui F,Qin X,et al.Diagnosis Accuracy and Prognostic Significance of the Dickkopf-1 Protein in Gastrointestinal Carcinomas:Systematic Review and Network Meta-analysis[J].J Cancer,2020,11(24):7091-7100. [16]贾凤林,曲海波,宁刚,等.卵巢正常大小卵巢癌综合征18例多层螺旋CT检查结果分析[J].实用妇产科杂志,2014,30(7):518-520. [17]Kanda M,Sonoyama A,Ohara N.Normal-sized ovary carcinoma syndrome(NOCS)detected with FDG-PET/CT[J].Eur J Gynaecol Oncol,2014,35(5):597-599. [18]Muro K,Van Cutsem E,Narita Y,et al.Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer:a JSMO-ESMO initiative endorsed by CSCO,KSMO,MOS,SSO and TOS[J].Ann Oncol,2019,30(1):19-33. [19]Glasgow SC,Gaertner W,Stewart D,et al.The American Society of Colon and Rectal Surgeons,Clinical Practice Guidelines for the Management of Appendiceal Neoplasms[J].Dis Colon Rectum,2019,62(12):1425-1438.

相似文献/References:

[1]刘海兵,汪洪雷.超声Finkler评分联合血清CA125、CA724用于卵巢肿瘤良恶性鉴别诊断中的应用价值[J].医学信息,2022,35(20):56.[doi:10.3969/j.issn.1006-1959.2022.20.013]
　LIU Hai-bing,WANG Hong-lei.Application Value of Ultrasound Finkler Score Combined with Serum CA125 and CA724 in Differential Diagnosis of Benign and Malignant Ovarian Tumors[J].Medical Information,2022,35(08):56.[doi:10.3969/j.issn.1006-1959.2022.20.013]
[2]仲月琴.二维超声联合彩色多普勒超声在鉴别诊断卵巢良恶性肿瘤中的价值[J].医学信息,2023,36(20):169.[doi:10.3969/j.issn.1006-1959.2023.20.035]
　ZHONG Yue-qin.Value of Two-dimensional Ultrasound Combined with Color Doppler Ultrasound in the Differential Diagnosis of Benign and Malignant Ovarian Tumors[J].Medical Information,2023,36(08):169.[doi:10.3969/j.issn.1006-1959.2023.20.035]

更新日期/Last Update: 1900-01-01